Swine fever, also known as hog cholera, is a highly contagious viral disease affecting domestic and wild pigs. The increasing prevalence of swine fever outbreaks across various countries such as China, Vietnam, and Russia is prompting farmers and regulatory authorities to focus on preventive measures such as vaccination. Swine fever vaccines help develop immunity against Classical Swine Fever Virus and African Swine Fever Virus, thereby preventing transmission and occurrence of the disease. Some of the commonly used swine fever vaccines include the C-strain vaccine, E2-Subunit vaccine, and the Live Attenuated Vaccine.

The global Swine Fever Vaccine Market is estimated to be valued at US$ 3323.81 Billion in 2024 and is expected to exhibit a CAGR Of 11% over the forecast period 2024 To 2031, as highlighted in a new report published by Coherent Market Insights.

The growing meat consumption worldwide and increasing demand for pork are fueling the mass production of swine. This has augmented the risk of infectious disease outbreaks, thereby driving the need for preventive vaccination among pig populations.

Market Dynamics:

One of the major drivers propelling the swine fever vaccine market growth is the growing demand for swine disease control. Swine fever outbreaks can lead to severe economic losses for farmers and trading partners due to animal culling and international trade restrictions. Furthermore, loss of pigs means loss of food sources and livelihood for many people globally. Therefore, governments and international organizations are promoting vaccination programs to curb the spread of swine fever viruses and mitigate the impact of outbreaks. For instance, in 2018, the FAO launched a global eradication program and emergency appeal to control the devastating African swine fever outbreaks in China and other affected regions in Asia and Europe. Such initiatives are creating high demand for swine fever vaccines.

Additionally, the increasing global meat consumption, particularly pork meat, is another key factor augmenting the growth of the pork industry. As per the U.S. Pork Center of Excellence, worldwide pork consumption increased by 34% between 2000 and 2020. This has raised the number of pigs reared for commercial meat production significantly over the years. The intensification and scaling up of pig farming practices have magnified the risk of infectious disease transmission. Thus, large-scale commercial pig producers are opting for vaccination to safeguard their herds and minimize

Segment Analysis

The global swine fever vaccine market is dominated by the conventional vaccines segment. Conventional swine fever vaccines are widely used owing to their effectiveness in providing protection against Classical Swine Fever Virus. These vaccines help prevent outbreaks of swine fever and reduce significant economic losses to pig farmers. The live attenuated vaccines sub-segment within conventional vaccines holds the largest market share and is expected to remain the dominating segment over the forecast period.

PEST Analysis

Political: Governments of various countries are focused on controlling outbreaks of swine fever through vaccination programs. Supportive policies and regulations for vaccine production and usage have been formulated.

Economic: Rising demand for pork due to growing population and incomes is driving the market. However, outbreaks of swine fever result in huge losses to farmers and the overall economy. Vaccines help reduce these losses.

Social: Swine fever negatively impacts livelihoods of farmers dependent on pig farming. Vaccination programs are thus crucial to protect local communities involved in pig rearing.

Technological: Advanced cell culture technologies and antigen production methods are being used to develop more effective newer generation swine fever vaccines.

Key Takeaways

The Global Swine Fever Vaccine Market Demand is expected to witness high growth over the forecast period.

Regional analysis:

The Asia Pacific region accounts for the largest share of the global swine fever vaccine market led by China and India. These countries are home to a huge pig population and regular outbreaks of swine fever, creating significant demand for vaccines. Government vaccination programs supplement private usage to control the spread of the disease.

Key players operating in the swine fever vaccine market are dbWatch AS, eG Innovations, Heroix Corporation, Nagios Enterprises, LLC, Paessler AG, Quest Software Inc., Red Gate Software Ltd., Sematext Group, SolarWinds Worldwide, LLC, and VirtualMetric. These players have adopted various strategies to increase their market penetration and strengthen their position in the industry.

Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it